Waters Corporation Management Presentation. July 2018
|
|
- Antony Parrish
- 5 years ago
- Views:
Transcription
1 Waters Corporation Management Presentation July 2018
2 Cautionary Statements This presentation may contain forward-looking statements regarding future results and events. For this purpose, any statements that are not statements of historical fact may be deemed forward-looking statements. Without limiting the foregoing, the words, may, will, should, feels, believes, anticipates, plans, expects, intends, suggests, appears, estimates, projects, and similar expressions, whether in the negative or affirmative, are intended to identify forward-looking statements. Forward-looking statements are based on current expectations and assumptions and currently available data, and are neither predictions nor guarantees of future events or performance. You should not place undue reliance on forward-looking statements, which speak only as of the date hereof and should not be relied upon as representing the Company s estimates or views as of any date subsequent to the date of this presentation. We do not undertake to update or revise any forward-looking statements after they are made, whether as a result of new information, future events, or otherwise, except as required by applicable law. The Company s actual future results may differ significantly from the results discussed in the forward-looking statements within this presentation for a variety of reasons, including and without limitation, foreign exchange rate fluctuations potentially affecting translation of the Company s future non-u.s. operating results; the impact on demand among the Company s various market sectors from economic, sovereign and political uncertainties; the effect on the Company s financial results from the United Kingdom voting to exit the European Union; fluctuations in expenditures by the Company s customers, in particular large pharmaceutical companies; introduction of competing products by other companies and loss of market share; pressures on prices from competitors and/or customers; regulatory, economic and competitive obstacles to new product introductions; other changes in demand from the effect of mergers and acquisitions by the Company s customers; increased regulatory burdens as the Company s business evolves, especially with respect to the U.S. Food and Drug Administration and U.S. Environmental Protection Agency, among others; impact of the newly enacted tax reform in the United States; shifts in taxable income in jurisdictions with different effective tax rates; the outcome of tax examinations or changes in respective country legislation affecting the Company s effective tax rate; the effect of the adoption of new accounting standards; the ability to access capital, maintain liquidity and service our debt in volatile market conditions, particularly in the U.S., as a large portion of the Company s cash is held and operating cash flows are generated outside the U.S.; environmental and logistical obstacles affecting the distribution of products and risks associated with lawsuits and other legal actions, particularly involving claims for infringement of patents and other intellectual property rights. For discussion of these and other risks that we face, please consult the Risk Factors section of the Company s most recent Annual Report on Form 10-K for the year ended December 31, 2017 as filed with the Securities and Exchange Commission on February 27, This presentation contains certain non-gaap measures, which are provided to assist in an understanding of the Company s business and its performance. These measures should always be considered in conjunction with the appropriate GAAP measure. Reconciliations of non-gaap amounts to the GAAP amounts are available in the appendix of this presentation, on the Company s website, or in the Company s historical Form 8-K filings with the SEC. 2
3 Building on a Strong Foundation of Values 60 Years of Sharp Focus on Serving our Key Stakeholders Deliver Benefit Deliver Benefit comes in a whole lot of different ways. You deliver benefit to your customers; you deliver benefit to your employees; you deliver benefit to your stockholders; you deliver benefit to the world. The secondary benefit, if the customer is having success, is that benefit is being delivered to somebody else. So, in effect, you change the world. James L. Waters, Founder 3
4 Our Purpose Inspires Innovation that Matters Advancing Human Health and Well-Being Through Advanced Analytical Measurement Can I sell this coffee to the EU? Does this new composite have the right mechanical properties? Does our new drug give us the results we expect? What poisoned this patient? Will this ADC deliver its cytotoxic payload effectively? Is my water safe to drink? Can we release this batch? 4
5 Waters Today High Performing and High Potential Global Technology Leader $13 Billion market served $2.3B annual sales $612M free cash flow 1 31% operating margin 1 15% ROIC 1 Company figures reflect full-year 2017 financial results. R&D Centers 1 Non-GAAP measure: see reconciliations on Company s website. Manufacturing Major Sales Offices 7,000 employees worldwide active in 125 countries 52% technology sales and services employees 38% employees with 10+ years of service 5
6 Q Results Q Q Growth Constant Currency Sales (millions) $558 $596 7% 5% Earnings Per Share 2 $1.76 $ % N/A Growth by Product & Markets 1 +4% +12% Instruments & Software 0% Consumables +6% Services +9% Waters Instruments +12% Services +11% TA Instruments +5% Pharma +4% Pharma + Industrial 6 % +3% Industrial Government + 6 % & Academic +13% Gov t/acad. + 6 Total % Growth by Major Geography 1 U.S. (2%) 1 Sales, product, and geography growth rates are in constant currency. See GAAP to non-gaap reconciliations in the appendix and on Company s website. 2 Stated as non-gaap adjusted earnings per share. See GAAP to non-gaap reconciliations on the Company s website. Europe + 5% India 0% China + 14% Japan + 2% 6
7 Year-to-Date Q Results Q Q Growth Constant Currency Sales (millions) $1,056 $1,127 7% 3% Earnings Per Share 2 $3.22 $ % N/A Growth by Product & Markets 1 +3% +9% Instruments & Software (2%) Consumables +7% Services +7% Waters Instruments +10% Services +8% TA Instruments +3% Pharma +4% Pharma + Industrial 6 % 0% Industrial Government + 6 % & Academic +10% Gov t/acad. + 6 Total % Growth by Major Geography 1 1 Sales, product, and geography growth rates are in constant currency. See GAAP to non-gaap reconciliations in the appendix and on Company s website. 2 Stated as non-gaap adjusted earnings per share. See GAAP to non-gaap reconciliations on the Company s website. Europe U.S % 4% India (5%) China + 11% Japan 0% 7
8 Focused on Long-Term Value Creation Highly Differentiated Strategic Position in Structurally Attractive Markets Clear Growth Strategy Driven by Organic Innovation Opportunity for Continuous Operational Improvement Committed to Judicious Use of Capital Performance-Oriented Culture and Management Team 8
9 Strategic Position Very Selective About Where We Compete Waters competes in 20% of the $57B global analytical instruments market Specialty segments growing faster than the total market $44B Analytical Instruments Market $13B Analytical instrument market is based on industry data and management estimates. 9
10 Strategic Position High-Value Technology Portfolio Sophisticated, high-precision specialty measurement technologies for the most demanding applications 10
11 Strategic Position Increasingly Attractive Business Mix 52% 53% 56% 41% 47% 49% 26% 34% 37% PHARMA RECURRING REVENUES ASIA Government/ Academic 13 % Pharma 56 % Recurring Revenue Instruments & Informatics 49 % 51 % Asia 37 % Americas 35 % Industrial 31 % 2017 sales numbers: 100% = $2.3B Reporting Mix Product Mix Europe 28 % Geographic Mix 11
12 Strategic Position Strategic Context The Broad Outlook for Advanced Measurement Technologies is Very Promising! 6.0% of Global GDP Up from 5.2% in 2000 (WHO report, 2015) 160 million people added to global middle class each of the next five years (Brookings Institute, 2017) The world is demanding more and better measurement by 2050, the world population will increase by 28% 12
13 Strategic Position Global Trends Shaping Our Strategy Global expansion of patient access to medicines Increasing complexity of biologic molecules Rising standards for materials performance and quality Increasing regulation and safety standards for food Growing medical research funding Unmet measurement needs in clinical diagnostics Increasing Customer Needs in High-Value Measurement Data security and integrity More accessible technologies Better, complete systems Applications expertise 13
14 Innovation Strategy Waters Vision and Corporate Strategy Waters is the world s leading specialty measurement company, delivering benefit through innovations and people that enable customer success in the life, materials, and food sciences. WHERE WE COMPETE: Serve the most demanding markets and customers HOW WE COMPETE: Compete on the basis of focus, innovation and quality of the total customer experience 14
15 Innovation Strategy Organic Innovation is our Core Growth Strategy Three Elements of Waters Innovation Innovation to Drive the Core Aimed at the near-term product pipeline Focused and disciplined Innovation that keeps us competitive Transformational Engineering Redefining innovation for next generation systems Informed by strategy Innovation that will change the basis of competition Breakthrough Innovation Thinking differently Harnessing the limitless potential of mass spectrometry Innovation that will one day change the world 15
16 Innovation Strategy Waters Business Portfolio and Strategy Summary PHARMA MATERIALS FOOD & ENVIRONMENTAL CLINICAL BIOMEDICAL RESEARCH Total Market Size $16B $13B $14B $5B $9B Waters Chosen Market Chosen Market Growth MSD + MSD - MSD + MSD MSD+ Waters Business Strategy Fortify core Pharma position, and win BioPharma with innovation Build Materials leadership and scale by leveraging two valuable brands Build Food testing solutions and market focus to drive share gains Solidify general-use IVD, and nurture intended-use IVD innovations Focus on Metabolomics and targeted Panomics workflows 16
17 Operating Efficiency Specialty Model Drives Industry-Leading Margins Unique product mix gradually trending to more profitable, recurring service, chemistry and informatics lines Margin structure reflects differentiated product, market and geography mix, with ongoing opportunity for modest improvement Informatics 11 % Chemistry 16 % Service 33 % Product Mix Instruments 40 % 2017 numbers: 100% = $2.3B 17
18 Operating Efficiency Track Record of Consistent Growth and Earnings Leverage Revenue = 5% Operating Income = 7% EPS = 11% $2,309 $705 $7.49 $1,844 $542 $4.93 $1,473 $370 $ REVENUE (MILLIONS) OPERATING INCOME (MILLIONS) EPS Revenue and Operating Income Growth: 10-year CAGR is in constant currency (as reported 5% and 7%, respectively). See reconciliations in the appendix. Operating Income & EPS: exclude the after tax impact of special items disclosed. See GAAP to Non-GAAP reconciliations on the Company s website. 18
19 Operating Efficiency Driving Operating Leverage 10-year Operating Income CAGR 7% KEY DRIVERS 25.1% 29.4% 30.5% Business Mix Leveraging Growth OPERATING MARGINS Operating Improvement Initiatives Disciplined Expense Management Operating Margin and Operating Income: exclude the after tax impact of special items disclosed. See GAAP to Non-GAAP reconciliations in the appendix. Operating Income Growth: 10-year CAGR is in constant currency (as reported 7%). See reconciliations in the appendix. 19
20 Priorities for Capital Allocation Capital Discipline Free Cash Flow Balance Sheet Cash Debt Capacity Invest in growing the business Maintain financial strength and flexibility Return capital to shareholders Organic innovation Capital expenditure Acquisitions & investments Strong, flexible balance sheet Optimal capital structure Share repurchase 20
21 Waters is a purpose-driven company VALUES Winning Culture VISION Waters is the world s leading specialty measurement company, delivering benefit through innovations and people that enable customer success in the life, materials, and food sciences. Improve human health and well being through the application of the most advanced specialty measurement technologies 21
22 Execution Winning Culture Robust core management processes establish annual execution priorities Strategy Clear set of choices that establish Waters differentiation and pathway to superior value creation Annual Operating Plan Annual investment planning for product portfolio and commercial operations Integrated Talent Management Talent acquisition and development, structural alignment, performance management, and incentives Annual Priorities GROWTH is our mandate INNOVATION to change the world QUALITY is everyone s job CUSTOMER experience excellence PEOPLE create the Waters difference 22
23 Focused on Long-Term Value Creation Highly Differentiated Strategic Position in Structurally Attractive Markets Clear Growth Strategy Driven by Organic Innovation Opportunity for Continuous Operational Improvement Committed to Judicious Use of Capital Performance-Oriented Culture and Management Team 23
24
25 Reconciliation of GAAP to Adjusted Non-GAAP Financial Measures
26 Non-GAAP Financial Measures This presentation contains financial measures, such as constant currency growth rate, adjusted operating income, adjusted earnings per diluted share and adjusted operating income, among others, which are considered non-gaap financial measures under applicable U.S. Securities and Exchange Commission rules and regulations. These non-gaap financial measures should be considered supplemental to and not a substitute for financial information prepared in accordance with generally accepted accounting principles (GAAP). The Company s definition of these non-gaap measures may differ from similarly titled measures used by others. The non-gaap financial measures used in this presentation adjust for specified items that can be highly variable or difficult to predict. The Company generally uses these non- GAAP financial measures to facilitate management s financial and operational decision-making, including evaluation of Waters Corporation s historical operating results, comparison to competitors operating results and determination of management incentive compensation. These non-gaap financial measures reflect an additional way of viewing aspects of the Company s operations that, when viewed with GAAP results and the reconciliations to corresponding GAAP financial measures, may provide a more complete understanding of factors and trends affecting Waters Corporation s business. Because non-gaap financial measures exclude the effect of items that will increase or decrease the Company s reported results of operations, management strongly encourages investors to review the Company s consolidated financial statements and publicly filed reports in their entirety. Reconciliations of the non-gaap financial measures to the most directly comparable GAAP financial measures are included in the appendix of this presentation. Additionally, please refer to the Company s website or its historical Form 8-K filings with the SEC, for explanations as to why the Company believes that presentation of these non-gaap financial measures provide useful information to investors. 26
27 Non-GAAP Financial Measures Waters Corporation and Subsidiaries Reconciliation of Actual GAAP Sales and Operating Income to Constant Currency For the Twelve Months Ended December 31, 2017, 2012 and 2007 (Unaudited) (In thousands) Sales as Reported in Actual U.S. Dollars $ 2,309,078 $ 1,843,641 $ 1,473,048 Impact of Foreign Currency Exchange (14,506) 38,900 (50,252) Sales in Constant Currency $ 2,294,572 $ 1,882,541 $ 1,422, Year Compound Annual Growth Rate 5.4% GAAP Operating Income $ 661,858 $ 511,490 $ 348,879 Net Impact of Non-GAAP Adjustments as Previously Disclosed 43,084 30,084 20,862 Adjusted Non-GAAP Operating Income $ 704,942 $ 541,574 $ 369,741 Adjusted Non-GAAP Operating Income Percentage 30.5% 29.4% 25.1% Adjusted Non-GAAP Operating Income $ 704,942 $ 541,574 $ 369,741 Impact of Foreign Currency Exchange (7,820) 13,611 (13,053) Adjusted Non-GAAP Operating Income in Constant Currency $ 697,122 $ 555,185 $ 356, Year Compound Annual Growth Rate in Constant Currency 7.5% 27
28 Non-GAAP Financial Measures Waters Corporation and Subsidiaries Reconciliation of GAAP to Adjusted Non-GAAP Net Sales by Operating Segment and Products & Services For the Three Months Ended June 30, 2018 and July 1, 2017 (Unaudited) (In thousands) Constant Three Months Ended Percent Currency Currency June 30, 2018 July 1, 2017 Change Impact Growth Rate (a) NET S ALES - OPERATING S EGMENT Waters $ 527,305 $ 497,780 6% $ 10,067 4% TA 68,914 60,470 14% 1,217 12% Total $ 596,219 $ 558,250 7% $ 11,284 5% NET S ALES - PRODUCTS & S ERVICES Waters Instruments $ 239,928 $ 238,548 1% $ 2,421 (0%) TA Instruments 49,812 43,466 15% % Total Instruments 289, ,014 3% 3,349 2% Waters Service 188, ,408 12% 5,101 9% TA Service 19,102 17,004 12% % Total Service 207, ,412 12% 5,390 9% Chemistry 99,129 90,824 9% 2,545 6% Total Recurring 306, ,236 11% 7,935 8% Total $ 596,219 $ 558,250 7% $ 11,284 5% (a) The Company believes that referring to comparable constant currency growth rates is a useful way to evaluate the underlying performance of Waters Corporation's net sales. Constant currency growth rate, a non-gaap financial measure, measures the change in net sales between current and prior year periods, ignoring the impact of foreign currency exchange rates during the current period. See description of non-gaap financial measures contained in this release. 28
29 Non-GAAP Financial Measures Waters Corporation and Subsidiaries Reconciliation of GAAP to Adjusted Non-GAAP Net Sales by Operating Segment and Products & Services For the Six Months Ended June 30, 2018 and July 1, 2017 (Unaudited) (In thousands) Constant Six Months Ended Percent Currency Currency June 30, 2018 July 1, 2017 Change Impact Growth Rate (a) NET S ALES - OPERATING S EGMENT Waters $ 998,451 $ 941,206 6% $ 32,218 3% TA 128, ,013 12% 2,932 9% Total $ 1,126,889 $ 1,056,219 7% $ 35,150 3% NET S ALES - PRODUCTS & S ERVICES Waters Instruments $ 438,031 $ 436,337 0% $ 10,818 (2%) TA Instruments 92,116 82,070 12% 2,232 10% Total Instruments 530, ,407 2% 13,050 (0%) Waters Service 362, ,142 11% 14,055 7% TA Service 36,322 32,943 10% 700 8% Total Service 398, ,085 11% 14,755 7% Chemistry 197, ,727 11% 7,345 7% Total Recurring 596, ,812 11% 22,100 7% Total $ 1,126,889 $ 1,056,219 7% $ 35,150 3% (a) The Company believes that referring to comparable constant currency growth rates is a useful way to evaluate the underlying performance of Waters Corporation's net sales. Constant currency growth rate, a non-gaap financial measure, measures the change in net sales between current and prior year periods, ignoring the impact of foreign currency exchange rates during the current period. See description of non-gaap financial measures contained in this release. 29
30 Non-GAAP Financial Measures Waters Corporation and Subsidiaries Reconciliation of GAAP to Adjusted Non-GAAP Net Sales by Geography and Markets For the Three Months Ended June 30, 2018 and July 1, 2017 (Unaudited) (In thousands) Constant Three Months Ended Percent Currency Currency June 30, 2018 July 1, 2017 Change Impact Growth Rate (a) NET S ALES - GEOGRAPHY U.S. $ 161,485 $ 164,374 (2%) $ - (2%) Rest of Americas 36,641 32,212 14% % Americas 198, ,586 1% 299 1% Europe 161, ,961 10% 7,700 5% China 109,709 94,104 17% 2,558 14% Japan 43,183 41,559 4% 758 2% India 35,167 36,252 (3%) (1,069) (0%) Rest of Asia 48,846 43,788 12% 1,038 9% Asia 236, ,703 10% 3,285 8% Total $ 596,219 $ 558,250 7% $ 11,284 5% NET S ALES - MARKETS Pharmaceutical $ 338,354 $ 319,650 6% $ 6,228 4% Industrial 183, ,531 5% 3,078 3% Government & Academic 74,201 64,069 16% 1,978 13% Total $ 596,219 $ 558,250 7% $ 11,284 5% (a) The Company believes that referring to comparable constant currency growth rates is a useful way to evaluate the underlying performance of Waters Corporation's net sales. Constant currency growth rate, a non-gaap financial measure, measures the change in net sales between current and prior year periods, ignoring the impact of foreign currency exchange rates during the current period. See description of non-gaap financial measures contained in this 30
31 Non-GAAP Financial Measures Waters Corporation and Subsidiaries Reconciliation of GAAP to Adjusted Non-GAAP Net Sales by Geography and Markets For the Six Months Ended June 30, 2018 and July 1, 2017 (Unaudited) (In thousands) Constant Six Months Ended Percent Currency Currency June 30, 2018 July 1, 2017 Change Impact Growth Rate (a) NET S ALES - GEOGRAPHY U.S. $ 308,306 $ 303,608 2% $ - 2% Rest of Americas 71,530 67,628 6% 717 5% Americas 379, ,236 2% 717 2% Europe 309, ,174 13% 25,059 4% China 203, ,226 14% 5,208 11% Japan 85,948 82,856 4% 2,929 0% India 65,843 69,770 (6%) (757) (5%) Rest of Asia 81,857 78,957 4% 1,994 1% Asia 437, ,809 6% 9,374 4% Total $ 1,126,889 $ 1,056,219 7% $ 35,150 3% NET S ALES - MARKETS Pharmaceutical $ 643,682 $ 599,460 7% $ 22,013 4% Industrial 345, ,834 3% 9,198 0% Government & Academic 137, ,925 13% 3,939 10% Total $ 1,126,886 $ 1,056,219 7% $ 35,150 3% (a) The Company believes that referring to comparable constant currency growth rates is a useful way to evaluate the underlying performance of Waters Corporation's net sales. Constant currency growth rate, a non-gaap financial measure, measures the change in net sales between current and prior year periods, ignoring the impact of foreign currency exchange rates during the current period. See description of non-gaap financial measures contained in this 31
Waters Corporation Management Presentation
Waters Corporation Management Presentation Chris O Connell Chairman & Chief Executive Officer January 2019 Cautionary Statements This presentation may contain forward-looking statements regarding future
More informationAnnual Reconciliation of GAAP to Adjusted Non-GAAP Financials as Disclosed in the Company s Annual Earnings Press Release
Annual Reconciliation of GAAP to Adjusted Non-GAAP Financials as Disclosed in the Company s Annual Earnings Press Release The 2017-2015 adjusted amounts presented below contain financial measures, such
More informationWaters $ 515,795 $ 503,904 2% $ (3,451) 3% TA 62,226 61,680 1% (294) 1% Total $ 578,021 $ 565,584 2% $ (3,745) 3%
Reconciliation of GAAP to Adjusted Non-GAAP Net Sales by Operating Segment, Products & Services, Geography and Markets Three Months Ended September 29, 2018 and September 30, 2017 (In thousands) Current
More informationWilliam Blair 35 th Annual Growth Stock Conference. June 9, 2015 NYSE: Q. Copyright 2014 Quintiles
William Blair 35 th Annual Growth Stock Conference June 9, 2015 Copyright 2014 Quintiles NYSE: Q Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains forward-looking
More informationDANAHER TO ACQUIRE GE LIFE SCIENCES BIOPHARMA BUSINESS ( GE Biopharma ) February 25, 2019
DANAHER TO ACQUIRE GE LIFE SCIENCES BIOPHARMA BUSINESS ( GE Biopharma ) February 25, 2019 Forward Looking Statements Statements in this presentation and the accompanying call that are not strictly historical,
More informationJefferies Global Healthcare Conference
Jefferies Global Healthcare Conference June 7, 2012 2012 PAREXEL International Safe Harbor This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act
More informationPAREXEL INTERNATIONAL
PAREXEL INTERNATIONAL Jefferies Healthcare Conference June 8, 2016 2015 PAREXEL INTERNATIONAL CORP. SAFE HARBOR This presentation contains forward-looking statements within the meaning of Section 27A of
More informationAvery Dennison. Baird 2018 Global Industrial Conference. Mitch Butier President and Chief Executive Officer. November 8, 2018
Avery Dennison November 8, 2018 Mitch Butier President and Chief Executive Officer 1 Forward-Looking Statements Certain statements contained in this document are "forward-looking statements" intended to
More informationWest Pharmaceutical Services, Inc. June 2016
West Pharmaceutical Services, Inc. June 2016 Safe harbor statement Cautionary Statement Under the Private Securities Litigation Reform Act of 1995 This slide presentation and any accompanying management
More informationPlease note that the following presentation contains financial projections and other forward-looking statements that are specific to the date of the
Please note that the following presentation contains financial projections and other forward-looking statements that are specific to the date of the presentation January 13, 2015 and should not be considered
More informationRaymond James 37 th Annual Institutional Investors Conference. March 8, 2016
Raymond James 37 th Annual Institutional Investors Conference March 8, 2016 Forward-looking statements and Non-GAAP financial measures Forward-looking statements Certain statements included in this presentation,
More informationAvery Dennison Jefferies Industrials Conference
Avery Dennison Jefferies Industrials Conference August 9, 2016 Anne Bramman SVP and Chief Financial Officer 1 Avery Dennison Investor Presentation Forward-Looking Statements Certain statements contained
More informationOur Transformation Continues. March 21, 2018
Our Transformation Continues March 21, 2018 Disclosure Regarding Forward-Looking Statements Forward-Looking Statements and Factors That May Affect Future Results: Throughout this presentation, we make
More informationAccelerating the Shift to Digital
Fourth Quarter 2017 Earnings Supplement Accelerating the Shift to Digital February 7, 2018 2017 Cognizant Forward Looking Statements and Non-GAAP Financial Measures This earnings supplement includes statements
More informationJune Dear Fellow Takeda Shareholder,
June 2018 Dear Fellow Takeda Shareholder, Since joining Takeda in April 2014, my mission has been to continue the transformation of Takeda in order to ensure that Takeda will be a successful company in
More informationOur Transformation Continues Sidoti NDR May 29-30, 2018
Our Transformation Continues Sidoti NDR May 29-30, 2018 Disclosure Regarding Forward-Looking Statements Forward-Looking Statements and Factors That May Affect Future Results: Throughout this presentation,
More informationA Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers
A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers Baird Healthcare Conference, September 2017 NASDAQ: NOVT 1 Safe Harbor Statement The statements in this presentation
More informationA global industrial technology company focused on environmental, energy, fluid handling industries. Integrated Clean Air Solutions for Industry
A global industrial technology company focused on environmental, energy, fluid handling industries 1 NOTES TO INVESTORS Forward-Looking Statements and Non-GAAP Information Any statements contained in this
More informationJEFFERIES GLOBAL HEALTHCARE CONFERENCE
JEFFERIES GLOBAL HEALTHCARE CONFERENCE November 20, 2014 2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED. SAFE HARBOR This presentation contains forward-looking statements within the meaning of Section
More informationAvery Dennison. Jefferies Industrials Conference August 9, Cindy Guenther VP Investor Relations and Treasury
Avery Dennison Jefferies Industrials Conference August 9, 2018 Cindy Guenther VP Investor Relations and Treasury 1 Forward-Looking Statements Certain statements contained in this document are "forward-looking
More informationNASDAQ 38th Investor Conference
NASDAQ 38th Investor Conference Mark Long Chief Financial Officer June 12, 2018 1 Forward-Looking Statements Safe Harbor Disclaimers This presentation contains forward-looking statements that involve risks
More informationHorizon Global First Quarter 2016 Earnings Presentation
Horizon Global First Quarter 2016 Earnings Presentation May 3, 2016 1 Safe Harbor Statement Forward-Looking Statements This presentation may contain "forward-looking statements" as defined in the Private
More informationMcKesson Corporation J.P. Morgan Healthcare Conference
McKesson Corporation J.P. Morgan Healthcare Conference John Hammergren Chairman and Chief Executive Officer Forward-Looking Statements Some of the information in this presentation is not historical in
More informationFISCAL YEAR 2018 THIRD QUARTER. Investor Presentation
FISCAL YEAR 2018 THIRD QUARTER Investor Presentation MARCH 2018 DISCLAIMER Forward Looking Safe Harbor Statement Certain statements contained in this presentation and in related comments by our management
More informationFourth Quarter and Full Year 2017 Results Conference Call. March 9, 2018
Fourth Quarter and Full Year 2017 Results Conference Call March 9, 2018 Forward-Looking Statements and Non-GAAP Financial Measures This presentation includes information that may constitute forward-looking
More informationTechnology Investors
Raymond James Technology Investors Conference December 5, 2017 Forward-Looking Statements Certain statements in this communication may contain forward-looking statements within the meaning of the Private
More informationANSYS, INC. FIRST QUARTER 2011 EARNINGS ANNOUNCEMENT PREPARED REMARKS May 5, 2011
ANSYS, INC. FIRST QUARTER 2011 EARNINGS ANNOUNCEMENT PREPARED REMARKS May 5, 2011 ANSYS is providing a copy of its prepared remarks in combination with its earnings announcement. This process and these
More informationMANAGEMENT S DISCUSSION AND ANALYSIS
MANAGEMENT S DISCUSSION AND ANALYSIS Q1 2017 February 1, 2017 Basis of Presentation This Management s Discussion and Analysis of the Financial Position and Results of Operations ( MD&A ) is the responsibility
More informationDave Carlucci Chairman and CEO IMS Health
Dave Carlucci Chairman and CEO IMS Health 1 March 11, 2009 Safe Harbor Certain statements we make today are forward-looking within the meaning of the US federal securities laws. These statements include,
More information2019 Preliminary Financial Outlook Call. December 19, 2018
2019 Preliminary Financial Outlook Call December 19, 2018 Legal Notices Forward-Looking Statements This presentation and the oral remarks made in connection herewith may contain forward-looking statements
More informationFiscal 2018 Third Quarter Results. 28 June 2018
Fiscal 2018 Third Quarter Results 28 June 2018 Safe harbor and non-gaap Cautionary Note Regarding Forward-Looking Statements: All statements in these materials and the related presentation that are not
More informationInvestor Overview Presentation. August 2018
Investor Overview Presentation August 2018 Forward-Looking Statements Statements about future results made in this presentation constitute forward-looking statements within the meaning of the Private Securities
More informationEarnings Webcast & Conference Call. Second Quarter and First Six Months of Fiscal Year 2018
Earnings Webcast & Conference Call Second Quarter and First Six Months of Fiscal Year 2018 2017 1 Forward-Looking Statements This presentation and other written or oral statements made from time to time
More informationSecond-Quarter Fiscal 2018 Financial Results & Update
Second-Quarter Fiscal 2018 Financial Results & Update February 5, 2018 TRANSFORMING HEALTHCARE TOGETHER Premier Inc. 2018 1 Forward-looking statements and non-gaap financial measures Forward-looking Statements
More informationDANAHER CORPORATION 2017 OVERVIEW
DANAHER CORPORATION 2017 OVERVIEW Forward Looking Statements Statements in this presentation that are not strictly historical, including any statements regarding events or developments that we believe
More informationJune Investor Presentation
June 2014 Investor Presentation Safe Harbor Certain statements included herein, including guidance and those that express management's objectives and the strategies to achieve those objectives, as well
More informationInvestor Relations Presentation. Delivering solutions, shaping the future
Investor Relations Presentation Delivering solutions, shaping the future Our Story Leader Differentiator Consistency Decades of experience Leading the dispensing solutions niche of the packaging industry
More informationPERFORMANCE AND TRAJECTORY
PERFORMANCE AND TRAJECTORY José (Joe) E. Almeida Chairman, President and CEO May 21, 2018 Safe Harbor Statement This presentation includes forward-looking statements concerning Baxter s financial results,
More informationFOURTH QUARTER & FULL YEAR 2018 EARNINGS CONFERENCE CALL. February 13, 2019
FOURTH QUARTER & FULL YEAR 2018 EARNINGS CONFERENCE CALL February 13, 2019 Overview Fourth quarter 2018 net revenue increased 13.3% o Organic growth of net revenue was 7.1% US organic growth was 6.3% International
More informationROTH Capital Partners 30 th Annual Conference. Monday, March 12, 2018
Monday, March 12, 2018 1 Forward-Looking Statements This presentation may contain "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements
More informationPowering healthcare provider success
Powering healthcare provider success Now and in the future 38 th Annual William Blair Growth Stock Conference June 12, 2018 TRANSFORMING HEALTHCARE TOGETHER Premier Inc. 2018 1 Forward-looking statements
More informationHorizon Global Reports Financial Results for the First Quarter 2017; Raises Full-Year 2017 Earnings Per Share Guidance and Announces Share Repurchase
Published on Horizon Global Investor Center (http://investors.horizonglobal.com) on 5/3/17 5:00 pm EDT Horizon Global Reports Financial Results for the First Quarter 2017; Raises Full-Year 2017 Earnings
More information2016 INVESTOR MEETINGS FIRST QUARTER 2016 WHIRLPOOL CORPORATION
2016 INVESTOR MEETINGS FIRST QUARTER 0 FIRST-QUARTER INVESTOR MEETINGS WHIRLPOOL CORPORATION ADDITIONAL INFORMATION This Presentation contains forward-looking statements about Whirlpool Corporation and
More informationCatalent to Acquire Cook Pharmica. September 19, 2017
Catalent to Acquire Cook Pharmica September 19, 2017 Disclaimer Statement Forward-Looking Statements This release contains both historical and forward-looking statements, including concerning the closing
More informationData. Insights. Results.
Image Area Data. Insights. Results. Raymond James 26 th Annual Institutional Investors Conference March 2005 Safe Harbor Certain statements we make today are forward-looking within the meaning of US federal
More informationRaymond James Institutional Investor Conference
Raymond James Institutional Investor Conference Marc Naughton Executive Vice President and Chief Financial Officer March 7, 2017 Cautionary Statement Regarding Forward-Looking Statements This presentation
More informationFiscal Year rd Quarter Earnings Conference Call
Fiscal Year 2017 3 rd Quarter Earnings Conference Call August 8, 2017 www.jacobs.com worldwide Forward-Looking Statement Disclaimer Certain statements contained in this presentation constitute forward-looking
More informationAccelerating the Shift to Digital
Investor Presentation Accelerating the Shift to Digital February 8, 2017 Forward Looking Statements and Non-GAAP Financial Measures This investor presentation includes statements which may constitute forward-looking
More informationRockwell Automation EPG Conference
Rockwell Automation EPG Conference Blake Moret Chief Executive Officer May 22, 2017 PUBLIC Copyright 2017 Rockwell Automation, Inc. All Rights Reserved. 1 SAFE HARBOR STATEMENT THIS PRESENTATION INCLUDES
More informationSeptember 11, Corporate Update. Rich Tobin, President & Chief Executive Officer
September 11, 2018 Corporate Update Rich Tobin, President & Chief Executive Officer Forward-Looking Statements and Non-GAAP Measures Our comments may contain forward-looking statements that are inherently
More informationJ.P. Morgan Healthcare Conference
J.P. Morgan Healthcare Conference Zane Burke President Marc Naughton Executive Vice President and Chief Financial Officer January 9, 2018 Cautionary Statement Regarding Forward-Looking Statements This
More informationWest Pharmaceutical Services, Inc. RBC Capital Markets Global Healthcare Conference
West Pharmaceutical Services, Inc. Eric M. Green, President & CEO William J. Federici, Senior Vice President & CFO February 21, 2018 Safe Harbor Statement Cautionary Statement Under the Private Securities
More informationJefferies Healthcare Conference
Jefferies Healthcare Conference Marc Naughton Executive Vice President and Chief Financial Officer June 7, 2017 Cautionary Statement Regarding Forward-Looking Statements This presentation may contain forward-looking
More information2015 Letter to Our Shareholders
2015 Letter to Our Shareholders 1 From Our Chairman & CEO Pierre Nanterme DELIVERING IN FISCAL 2015 Accenture s excellent fiscal 2015 financial results reflect the successful execution of our strategy
More informationPowering healthcare provider success
Powering healthcare provider success Now and in the future Investor Information September 2018 TRANSFORMING HEALTHCARE TOGETHER Premier Inc. 2018 1 Forward-looking statements and non-gaap financial measures
More informationUBIQUITI NETWORKS REPORTS FOURTH QUARTER FISCAL 2018 FINANCIAL RESULTS
UBIQUITI NETWORKS REPORTS FOURTH QUARTER FISCAL 2018 FINANCIAL RESULTS ~Revenues of $269.8 million~ ~ Initiates Dividend Program to Complement Existing Stock Repurchase Program ~ New York, NY - August
More informationFOSSIL GROUP, INC. REPORTS FIRST QUARTER FISCAL 2015 RESULTS; First Quarter Net Sales of $725 Million; Diluted EPS of $0.75
FOSSIL GROUP, INC. REPORTS FIRST QUARTER FISCAL 2015 RESULTS; First Quarter Net Sales of $725 Million; Diluted EPS of $0.75 Maintains Full Year Constant Currency Guidance and Provides Second Quarter Guidance
More informationIDEXX Laboratories Announces First Quarter Results
FOR IMMEDIATE RELEASE Contact: Merilee Raines, Chief Financial Officer, 1-207-556-8155 IDEXX Laboratories Announces First Quarter Results WESTBROOK, Maine, IDEXX Laboratories, Inc. (NASDAQ: IDXX), today
More informationBio-Techne Releases Second Quarter Fiscal 2016 Results
February 2, 2016 Bio-Techne Releases Second Quarter Fiscal 2016 Results MINNEAPOLIS, Feb. 2, 2016 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the second
More informationLOOKING statements. Forward
1 Forward LOOKING statements This presentation contains forward-looking statements regarding future events or the future financial performance of the Company that involve substantial risks and uncertainties.
More information34 th Annual J.P. Morgan Healthcare Conference. Steve Collis, President & CEO Tim Guttman, EVP & CFO
34 th Annual J.P. Morgan Healthcare Conference Steve Collis, President & CEO Tim Guttman, EVP & CFO January 12, 2016 Steve Collis President & CEO Cautionary Note Regarding Forward-Looking Statements Certain
More informationThird-Quarter Fiscal 2018 Financial Results & Update
Third-Quarter Fiscal 2018 Financial Results & Update May 7, 2018 TRANSFORMING HEALTHCARE TOGETHER Premier Inc. 2018 1 Forward-looking statements and non-gaap financial measures Forward-looking Statements
More informationFinancial Targets through 2022: Focus on Value Creation
Financial Targets through 2022: Focus on Value Creation /////////// Capital Markets Day London, December 5, 208 Wolfgang Nickl CFO Bayer AG Disclaimer Cautionary Statements Regarding Forward-Looking Information
More informationFourth Quarter and Fiscal 2016 Results. 20 October 2016
Fourth Quarter and Fiscal 2016 Results 20 October 2016 Safe harbor and non-gaap Cautionary Note Regarding Forward-Looking Statements: All statements in these materials and the related presentation that
More informationInvestor Relations Hologic
Investor Relations Hologic Hologic Announces Financial Results for Second Quarter of Fiscal 2017 -- GAAP Diluted EPS of $1.84 Increases 666.7%, Non-GAAP Diluted EPS of $0.50 Increases 6.4% -- -- Revenue
More informationAptar Reports Third Quarter Results
Aptar Reports Third Quarter Results Crystal Lake, Illinois, November 1, 2018 -- AptarGroup, Inc. (NYSE:ATR) today announced third quarter results. Third Quarter 2018 Summary Reported sales increased 7%
More informationIDEXX Laboratories Announces Second Quarter Results
FOR IMMEDIATE RELEASE Contact: Ed Garber, Director, Investor Relations, 1-207-556-8155 IDEXX Laboratories Announces Second Quarter Results Delivers 9% organic revenue growth and $1.10 EPS, driven by double-digit
More informationBio-Techne Releases Fourth Quarter Fiscal 2015 Results
August 6, 2015 Bio-Techne Releases Fourth Quarter Fiscal 2015 Results MINNEAPOLIS, Aug. 6, 2015 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the fourth
More informationDanaher to Acquire Beckman Coulter February 7, 2011
Danaher to Acquire Beckman Coulter February 7, 2011 Forward Looking Statements Statements in this presentation that are not strictly historical, including statements regarding the proposed acquisition,
More informationNCR Announces Fourth Quarter and Full Year 2018 Results
NCR Corporation Logo NCR Announces Fourth Quarter and Full Year 2018 Results February 7, 2019 ATLANTA--(BUSINESS WIRE)--Feb. 7, 2019-- NCR Corporation (NYSE: NCR) reported financial results today for the
More informationPAREXEL INTERNATIONAL REPORTS THIRD QUARTER FISCAL YEAR 2017 RESULTS
FOR IMMEDIATE RELEASE PAREXEL INTERNATIONAL REPORTS THIRD QUARTER FISCAL YEAR 2017 RESULTS Service revenue of $529.3 million, diluted EPS of $0.35; adjusted diluted EPS of $0.74 Company adopts new policy
More informationStericycle Investor Presentation Q NASDAQ: SRCL
Stericycle Investor Presentation Q3-2017 NASDAQ: SRCL Forward - Looking Statements Safe Harbor Statement: This press release may contain forward-looking statements that involve risks and uncertainties,
More informationA Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers
A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers Baird Industrial Conference, November 2017 Matthijs Glastra, Chief Executive Officer NASDAQ: NOVT 1 Safe Harbor Statement
More informationNorthern Technologies International Corporation. Fiscal 2019 First Quarter Investor Presentation
Northern Technologies International Corporation Fiscal 2019 First Quarter Investor Presentation Forward Looking Statements Statements contained in this presentation that are not historical information
More informationAccelerating our IPT strategy
Accelerating our IPT strategy GlaxoSmithKline plc and Pfizer Inc to form new world-leading Consumer Healthcare Joint Venture Transaction lays foundation for separation of GSK to create two new UK-based
More informationExl Reports 2017 First Quarter Results
May 2, 2017 Exl Reports 2017 First Quarter Results 2017 First Quarter Revenues of $183.0 Million, up 9.6% year over year Q1 Diluted EPS (GAAP) of $0.48, up from $0.40 in Q1 of 2016 Q1 Adjusted Diluted
More informationSunTrust Robinson Humphrey 2017 Financial Technology, Business & Government Services Summit
1 SunTrust Robinson Humphrey 2017 Financial Technology, Business & Government Services Summit December 2017 2017 NAVIGANT CONSULTING, INC. ALL RIGHTS RESERVED DISCLOSURE STATEMENT Statements included in
More informationPRUDENTIAL FINANCIAL, INC. FEBRUARY 2018
PRUDENTIAL FINANCIAL, INC. FEBRUARY 2018 FORWARD-LOOKING STATEMENTS AND NON-GAAP MEASURES Certain of the statements included in this presentation constitute forward-looking statements within the meaning
More informationIngersoll Rand s Acquisition of Precision Flow Systems (PFS) February 11, 2019
Ingersoll Rand s Acquisition of Precision Flow Systems (PFS) February 11, 2019 1 Safe Harbor This presentation contains forward-looking statements, which are statements that are not historical facts, including
More informationCombination Creates Leading Innovator in the Musculoskeletal Industry April 24, 2014
Combination Creates Leading Innovator in the Musculoskeletal Industry April 24, 2014 David Dvorak President and Chief Executive Officer Jim Crines EVP, Finance, and Chief Financial Officer Cautionary Statement
More informationjuly 2012 CEB to Acquire SHL Compelling Value Creation, Growth, and Scale Opportunity
july 2012 CEB to Acquire SHL Compelling Value Creation, Growth, and Scale Opportunity Safe Harbor Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities
More informationPraxair, Inc. Steve Angel Chairman, President and Chief Executive Officer. Credit Suisse Basic Materials Conference September 17, 2014
Praxair, Inc. Steve Angel Chairman, President and Chief Executive Officer Credit Suisse Basic Materials Conference September 17, 2014 Forward Looking Statement This document contains forward-looking statements
More informationA Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers
A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers February 2018 Matthijs Glastra, Chief Executive Officer NASDAQ: NOVT 1 Safe Harbor Statement The statements in this
More informationHelping Clients Win with Digital
First Quarter 2018 Earnings Supplement Helping Clients Win with Digital May 7, 2018 2017 Cognizant Forward Looking Statements and Non-GAAP Financial Measures This earnings supplement includes statements
More informationFirst Quarter Fiscal 2017 Financial Report
First Quarter Fiscal 2017 Financial Report For the three months ended March 31, 2017 and 2016 TSX: AVO AVIGILON CORPORATION MANAGEMENT S DISCUSSION AND ANALYSIS INTRODUCTION The following Management s
More informationInvestor Relations Presentation
Investor Relations Presentation Delivering solutions, shaping the future. Beauty + Home Food + Beverage Pharma Forward Looking Statements & Non-GAAP Financial Measures This presentation includes forward-looking
More informationQ4 Fiscal 2017 Earnings Commentary. March 27, 2018
Q4 Fiscal 2017 Earnings Commentary March 27, 2018 The financial measures discussed below include both GAAP and adjusted non-gaap financial measures. In connection with the restructuring of its ivivva operations,
More informationHORIZON GLOBAL DRIVEN TO DELIVER. 28 th Annual Roth Conference March 2016 NYSE: HZN
HORIZON GLOBAL DRIVEN TO DELIVER 28 th Annual Roth Conference March 2016 1 Safe Harbor Statement Forward-Looking Statements This presentation may contain "forward-looking statements" as defined in the
More informationebay INC. ANNOUNCES THIRD QUARTER 2007 FINANCIAL RESULTS
s ebay INC. ANNOUNCES THIRD QUARTER 2007 FINANCIAL RESULTS San Jose, Calif, October 17, 2007 ebay Inc. (Nasdaq: EBAY; www.ebay.com) reported financial results for its third quarter ended September 30,
More informationRockwell Automation. Company Overview August 2018 PUBLIC. Copyright 2018 Rockwell Automation, Inc. All Rights Reserved.
Rockwell Automation Company Overview August 2018 SAFE HARBOR STATEMENT THIS PRESENTATION INCLUDES STATEMENTS RELATED TO THE EXPECTED FUTURE RESULTS OF THE COMPANY AND ARE THEREFORE FORWARD-LOOKING STATEMENTS.
More informationUBIQUITI NETWORKS REPORTS RECORD FOURTH QUARTER FISCAL 2014 FINANCIAL RESULTS
UBIQUITI NETWORKS REPORTS RECORD FOURTH QUARTER FISCAL 2014 FINANCIAL RESULTS ~ Achieves Record Revenue and Earnings ~ ~ Posts Non-GAAP EPS of $0.56 Per Diluted Share ~ San Jose, Calif. - August 7, 2014
More information2013 INVESTOR MEETINGS May 2013
2013 May 2013 INVESTOR MEETINGS WHIRLPOOL CORPORATION ADDITIONAL INFORMATION This document contains forward-looking statements about Whirlpool Corporation and its consolidated subsidiaries ( Whirlpool
More informationFourth Quarter & Full-Year 2017 Earnings Thursday, March 1, 2018
Fourth Quarter & Full-Year 2017 Earnings Thursday, March 1, 2018 1 Forward-Looking Statements This presentation may contain "forward-looking statements" as defined in the Private Securities Litigation
More informationCIGNA AND EXPRESS SCRIPTS: EXPANDS GROWTH OPPORTUNITIES IMPROVES AFFORDABILITY CREATES DIFFERENTIATED SHAREHOLDER VALUE
CIGNA AND EXPRESS SCRIPTS: EXPANDS GROWTH OPPORTUNITIES IMPROVES AFFORDABILITY CREATES DIFFERENTIATED SHAREHOLDER VALUE March 2018 Important Information for Investors and Shareholders FORWARD LOOKING STATEMENTS
More informationOverview Presentation to Investors. February 2016
Overview Presentation to Investors February 2016 Forward-Looking Statements Statements about future results made in this presentation constitute forward-looking statements within the meaning of the Private
More informationCredit Suisse 6 th Annual Industrials Conference November 2018
Credit Suisse 6 th Annual Industrials Conference November 2018 Safe Harbor This presentation includes forward-looking statements which are statements that are not historical facts, including statements
More informationInvestor Deck December 2018
Investor Deck December 2018 Safe Harbor This presentation includes forward-looking statements which are statements that are not historical facts, including statements that relate to the mix of and demand
More informationMSCI. Raymond James 38 th Annual Institutional Investors Conference. Kathleen Winters, CFO. March 8, 2017
MSCI Raymond James 38 th Annual Institutional Investors Conference Kathleen Winters, CFO March 8, 2017 2017 MSCI Inc. All rights reserved. Please refer to the disclaimer at the end of this document. FORWARD
More informationQ Financial Results. February 26, 2018
Q4 2017 Financial Results February 26, 2018 Forward Looking Statements & Non-GAAP Financial Measures Forward-Looking Statements This presentation contains forward-looking statements within the meaning
More informationFourth Quarter and Fiscal 2018 Results. October 11, 2018
Fourth Quarter and Fiscal 2018 Results October 11, 2018 Safe harbor and non-gaap Cautionary Note Regarding Forward-Looking Statements: All statements in these materials and the related presentation that
More information